United States · Series C startup
4 rounds we have observed, with the 10 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$80Mraised across 4 rounds since 2006, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
F-Prime Capital
CMEA Ventures
Skyline Ventures
Excel Venture ManagementReported by fiercebiotech.comSEC filing: $45M sold, first sale May 2010
No investor was named in the report.
From a historical funding recordSEC filing: $10M sold, first sale Sept 2009
Reported by equityhelpdesk.com
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
Tetraphase Pharmaceuticals's investors include CMEA Ventures, Skyline Ventures, Mediphase Venture Partners, Flagship Pioneering, LLC and Fidelity Biosciences, and 5 more on record.
Tetraphase Pharmaceuticals has raised $80M across 4 rounds since 2006.
Tetraphase Pharmaceuticals's most recent round was a Series C of $45M in Jun 2010.
Its most recent round, $45M in Jun 2010, is also its largest on record.
Tetraphase Pharmaceuticals's first round on record, in Nov 2006, was backed by CMEA Ventures, Flagship Ventures and Skyline Ventures and 2 others.
Tetraphase Pharmaceuticals's latest named round is a Series C, in Jun 2010.
Tetraphase Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·